Effect of losartan on plasma C-reactive protein in type 2 diabetic patients with microabluminuria.
Tan
Kathryn
K
Chow
Wing-Sun
WS
Wong
Ying
Y
Shiu
Sammy
S
Tam
Sidney
S
D000419:Albuminuria / Q000188:drug therapy*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy; D005260:Female; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D012016:Reference Values
D000959:Antihypertensive Agents; D002097:C-Reactive Protein; D019808:Losartan